{"id":"https://openalex.org/W4389447013","doi":"https://doi.org/10.1212/wnl.94.15_supplement.2091","title":"Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials (2091)","display_name":"Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials (2091)","publication_year":2020,"publication_date":"2020-04-14","ids":{"openalex":"https://openalex.org/W4389447013","doi":"https://doi.org/10.1212/wnl.94.15_supplement.2091"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.94.15_supplement.2091","doi":"https://doi.org/10.1212/wnl.94.15_supplement.2091","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1212/wnl.94.15_supplement.2091","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101520745","display_name":"Jelena M. Pavlovic","orcid":"https://orcid.org/0000-0003-2049-6755","observed_orcids":["https://orcid.org/0000-0003-2049-6755"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jelena Pavlovic","raw_affiliation_strings":["Albert Einstein College of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057290642","display_name":"David W. Dodick","orcid":"https://orcid.org/0000-0002-9486-6790","observed_orcids":["https://orcid.org/0000-0002-9486-6790"]},"institutions":[{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Dodick","raw_affiliation_strings":["Mayo Clinic Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Arizona","institution_ids":["https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064028043","display_name":"Lawrence C. Newman","orcid":"https://orcid.org/0000-0002-2431-1570","observed_orcids":["https://orcid.org/0000-0002-2431-1570"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence Newman","raw_affiliation_strings":["Preston Robert Tisch Center for Men\u2019s Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preston Robert Tisch Center for Men\u2019s Health","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000448269","display_name":"Richard B. Lipton","orcid":"https://orcid.org/0000-0003-2652-2897","observed_orcids":["https://orcid.org/0000-0003-2652-2897"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Lipton","raw_affiliation_strings":["Albert Einstein College of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albert Einstein College of Medicine","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020915025","display_name":"Elyse G. Stock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093361","display_name":"Biohaven Pharmaceuticals (United States)","ror":"https://ror.org/00m2ky193","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093361"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elyse Stock","raw_affiliation_strings":["Biohaven Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biohaven Pharmaceuticals, Inc","institution_ids":["https://openalex.org/I4210093361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063535543","display_name":"Alexandra Thiry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093361","display_name":"Biohaven Pharmaceuticals (United States)","ror":"https://ror.org/00m2ky193","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093361"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra Thiry","raw_affiliation_strings":["Biohaven Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biohaven Pharmaceuticals, Inc","institution_ids":["https://openalex.org/I4210093361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058152350","display_name":"Charles M. Conway","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093361","display_name":"Biohaven Pharmaceuticals (United States)","ror":"https://ror.org/00m2ky193","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093361"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Conway","raw_affiliation_strings":["Biohaven Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biohaven Pharmaceuticals, Inc","institution_ids":["https://openalex.org/I4210093361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001453416","display_name":"Christopher Jensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093361","display_name":"Biohaven Pharmaceuticals (United States)","ror":"https://ror.org/00m2ky193","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093361"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Jensen","raw_affiliation_strings":["Biohaven Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biohaven Pharmaceuticals, Inc","institution_ids":["https://openalex.org/I4210093361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055564981","display_name":"Beth A. Morris","orcid":"https://orcid.org/0009-0006-4347-2042","observed_orcids":["https://orcid.org/0009-0006-4347-2042"]},"institutions":[{"id":"https://openalex.org/I4210093361","display_name":"Biohaven Pharmaceuticals (United States)","ror":"https://ror.org/00m2ky193","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093361"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beth Morris","raw_affiliation_strings":["Biohaven Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biohaven Pharmaceuticals, Inc","institution_ids":["https://openalex.org/I4210093361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069362203","display_name":"Vladimir Coric","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093361","display_name":"Biohaven Pharmaceuticals (United States)","ror":"https://ror.org/00m2ky193","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093361"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vladimir Coric","raw_affiliation_strings":["Biohaven Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biohaven Pharmaceuticals, Inc","institution_ids":["https://openalex.org/I4210093361"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060859207","display_name":"Robert S. Croop","orcid":"https://orcid.org/0009-0004-0151-1192","observed_orcids":["https://orcid.org/0009-0004-0151-1192"]},"institutions":[{"id":"https://openalex.org/I4210093361","display_name":"Biohaven Pharmaceuticals (United States)","ror":"https://ror.org/00m2ky193","country_code":"US","type":"company","lineage":["https://openalex.org/I4210093361"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Croop","raw_affiliation_strings":["Biohaven Pharmaceuticals, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biohaven Pharmaceuticals, Inc","institution_ids":["https://openalex.org/I4210093361"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3564,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.61613517,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"94","issue":"15_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10420","display_name":"Intracranial Aneurysms: Treatment and Complications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rimegepant","display_name":"rimegepant","score":1.0},{"id":"https://openalex.org/keywords/acute-migraine-treatment","display_name":"acute migraine treatment","score":0.8550000190734863},{"id":"https://openalex.org/keywords/migraine-prevention","display_name":"migraine prophylaxis","score":0.722000002861023},{"id":"https://openalex.org/keywords/triptans","display_name":"triptans","score":0.6209999918937683},{"id":"https://openalex.org/keywords/cgrp-receptor-antagonists","display_name":"CGRP receptor antagonists","score":0.7020000219345093},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.5929999947547913},{"id":"https://openalex.org/keywords/migraine","display_name":"migraine","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6960461139678955},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.6584488153457642},{"id":"https://openalex.org/C3017807917","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Acute migraine","level":4,"score":0.4406338036060333},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37755098938941956},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.2841097116470337},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07692539691925049},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.94.15_supplement.2091","doi":"https://doi.org/10.1212/wnl.94.15_supplement.2091","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1212/wnl.94.15_supplement.2091","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4367303151","https://openalex.org/W4389448951","https://openalex.org/W4389445407","https://openalex.org/W7161589877","https://openalex.org/W7211988212","https://openalex.org/W4389448178","https://openalex.org/W4411183275","https://openalex.org/W3111685616","https://openalex.org/W2959015323","https://openalex.org/W7155389104"],"abstract_inverted_index":{"Objective:":[0],"This":[1],"analysis":[2],"was":[3,232,239,260,269,605,721,882,954],"conducted":[4,81],"to":[5,96,113,121,271],"compare":[6],"the":[7,14,32,63,152,222,228,263,307,480,581,629,695,856,928],"efficacy":[8,59,167],"of":[9,17,34,66,77,86,91,119,243,266,320,368,454,482,484,510,583,585,697,699,858,860,930,932],"rimegepant":[10,97,193,213,259],"with":[11,57,88,227,529,570,652,683,755,784,815,844,916],"placebo":[12,110,170,181,195],"for":[13,139,166,192,204,212,218,262,393,450,477,517,549,558,578,640,671,692,743,772,803,832,853,904,925],"acute":[15,64,264],"treatment":[16,27,65,265],"migraine":[18,22,37,117,128,176,250],"in":[19,62,82,241,253,545,596,601,617,662,710,717,733,764,794,824,871,878,894,943,950,966],"subjects":[20,164,247],"taking":[21,248],"preventive":[23,38,41,127,177,251],"medication.":[24],"Background:":[25],"Acute":[26],"is":[28,48,278,297],"still":[29],"required":[30],"by":[31,299],"majority":[33],"patients":[35],"using":[36,175],"medication":[39,129,178],"since":[40],"therapy":[42],"rarely":[43],"eliminates":[44],"all":[45],"attacks.":[46],"Rimegepant":[47,231],"an":[49,546,608,724,885,957],"orally":[50],"administered":[51],"small":[52],"molecule":[53],"CGRP":[54],"receptor":[55],"antagonist":[56],"demonstrated":[58],"and":[60,102,111,149,194,214,234,294,375,384,431,468,490,507,537,587,633],"safety":[61],"migraine.":[67,92],"Design/Methods:":[68],"Three":[69],"Phase":[70,255],"3":[71,254,256],"double-blind,":[72],"randomized,":[73],"placebo-controlled,":[74],"multicenter":[75],"trials":[76],"identical":[78],"design":[79],"were":[80,94,130,134,146,174,196,208,225],"adults":[83],"\u226518":[84],"years":[85],"age":[87],"\u22651-year":[89],"history":[90],"Subjects":[93,125],"randomized":[95],"75":[98,104],"mg":[99,105],"(Studies":[100],"301":[101],"302),":[103],"ODT":[106],"(Study":[107],"303),":[108],"or":[109,389,448,526,567,649,680,752,781,812,841,913],"instructed":[112],"treat":[114],"a":[115,136,279,521,562,644,675,747,776,807,836,908],"single":[116],"attack":[118],"moderate":[120],"severe":[122],"pain":[123,147],"intensity.":[124],"receiving":[126],"eligible":[131],"if":[132],"they":[133,207],"on":[135,479,520,561,580,643,674,694,746,775,806,835,855,907,927],"stable":[137],"regimen":[138],"\u22653":[140],"months":[141],"prescreening.":[142],"The":[143],"coprimary":[144],"endpoints":[145],"freedom":[148,150],"from":[151,221,288,499,625],"most":[153],"bothersome":[154],"symptom":[155],"(MBS)":[156],"at":[157],"2":[158],"hours":[159],"postdose.":[160],"Results:":[161],"Of":[162],"3507":[163],"evaluated":[165],"(rimegepant":[168,179],"n=1749,":[169],"n=1758),":[171],"547":[172],"(15.6%)":[173],"n=272,":[180],"n=275).":[182],"In":[183],"these":[184],"subjects,":[185],"pooled":[186,229],"2-hour":[187],"pain-free":[188],"rates":[189],"(95%":[190],"CI)":[191],"20.6%":[197],"(15.8,":[198],"25.4)":[199],"vs":[200],"10.2%":[201],"(6.6,":[202],"13.8);":[203],"MBS":[205],"freedom,":[206],"37.1%":[209],"(31.4,":[210],"42.9)":[211],"20.4%":[215],"(15.6,":[216],"25.1)":[217],"placebo.":[219,272],"Results":[220],"individual":[223,236],"studies":[224],"consistent":[226],"results.":[230],"well-tolerated,":[233],"no":[235],"adverse":[237],"event":[238],"reported":[240],">2%":[242],"subjects.":[244],"Conclusions:":[245],"Among":[246],"concurrent":[249],"medications":[252],"clinical":[257],"trials,":[258],"effective":[261],"migraine;":[267],"tolerability":[268],"similar":[270],"Disclosure:":[273],"Jelena":[274],"Pavlovic,":[275],"MD,":[276,305],"PhD,":[277],"consultant":[280],"and/or":[281,593,614,659,707,730,761,791,821,868,891,940,963],"advisory":[282,523,564,646,677,749,778,809,838,910],"panel":[283],"member,":[284],"has":[285,474,495,513,541,554,575,621,636,667,689,739,768,799,828,850,900,922],"received":[286,475,496,514,542,555,576,622,637,668,690,740,769,800,829,851,901,923],"honoraria":[287],"Alder":[289,313],"Biopharmaceuticals,":[290],"Allergan,":[291,315,530],"Amgen,":[292,316,380,532],"Biohaven,":[293,326,533],"Promius.":[295],"She":[296],"funded":[298],"NIH/NIA":[300],"K23":[301],"AG049466-01A.David":[302],"W.":[303],"Dodick,":[304],"reports":[306],"following":[308],"conflicts:":[309],"Personal":[310],"fees:":[311,379],"AEON,":[312],"BioPharmaceuticals,":[314],"Amzak":[317],"Health,":[318],"Association":[319],"Translational":[321],"Medicine,":[322],"Autonomic":[323],"Technologies,":[324,487],"Axsome,":[325],"Charleston":[327],"Laboratories,":[328],"Clexio,":[329],"Daniel":[330],"Edelman":[331],"Inc.,":[332],"Dr":[333],"Reddy\u2019s":[334],"Laboratories/Promius,":[335],"electroCore":[336],"LLC,":[337],"Eli":[338,381],"Lilly,":[339,382],"eNeura,":[340],"Equinox,":[341],"Foresite":[342],"Capital,":[343],"Impel,":[344],"Ipsen,":[345],"Neurolief,":[346],"Nocira,":[347],"Novartis,":[348,534],"Oppenheimer,":[349],"Pieris,":[350],"PSL":[351],"Group":[352],"Services,":[353],"Revance,":[354],"Salvia,":[355],"Satsuma,":[356],"Sun":[357],"Pharma":[358],"(India),":[359],"Supernus,":[360,536],"Teva,":[361,535],"Theranica,":[362],"University":[363,398,421],"Health":[364],"Network,":[365],"Upjohn":[366],"(Division":[367],"Pfizer),":[369],"Vedanta,":[370],"WL":[371],"Gore,":[372],"XoC,":[373],"Zosano,":[374],"ZP":[376],"Opco;":[377],"Speaking":[378],"Lundbeck,":[383],"Novartis":[385],"Canada;":[386],"CME":[387],"fees":[388,447],"royalty":[390],"payments:":[391],"Academy":[392,453],"Continued":[394],"Healthcare":[395],"Learning,":[396],"Cambridge":[397],"Press,":[399,422],"Catamount,":[400],"Chameleon,":[401],"Global":[402,405,408],"Access":[403],"Meetings,":[404],"Life":[406],"Sciences,":[407],"Scientific":[409],"Communications,":[410,416],"Haymarket,":[411],"HealthLogix,":[412],"Medicom":[413],"Worldwide,":[414],"MedLogix":[415],"Mednet,":[417],"Miller":[418],"Medical,":[419],"Oxford":[420],"PeerView,":[423],"Universal":[424],"Meeting":[425],"Management,":[426],"UpToDate":[427],"(Elsevier),":[428],"WebMD":[429],"Health/Medscape,":[430],"Wolters":[432],"Kluwer":[433],"Health;":[434,444],"Consulting":[435],"without":[436],"fee:":[437],"Aural":[438],"Analytics,":[439],"Epien,":[440,485],"Healint,":[441],"Second":[442],"Opinion/Mobile":[443],"Professional":[445],"society":[446],"reimbursement":[449],"travel:":[451],"American":[452,456,459,462,500],"Neurology,":[455],"Brain":[457],"Foundation,":[458,464,502,505],"Headache":[460,466,470,631],"Society,":[461,467],"Migraine":[463,501,626],"Canadian":[465],"International":[469],"Society.":[471],"Dr.":[472,493,539,552,573,589,603,610,619,655,665,687,703,719,726,737,757,766,787,797,817,826,848,864,880,887,898,920,936,952,959],"Dodick":[473,494],"compensation":[476,516,544,557,577,639,670,691,742,771,802,831,852,903,924],"serving":[478,519,560,579,642,673,693,745,774,805,834,854,906,926],"Board":[481,582,696,857,929],"Directors":[483,584,698,859,931],"King-Devick":[486],"Matterhorn,":[488],"Ontologics,":[489],"Precon":[491],"Health.":[492],"research":[497,600,623,716,877,949],"support":[498,624],"Henry":[503],"Jackson":[504],"PCORI,":[506],"US":[508],"Department":[509],"Defense.Dr.":[511],"Newman":[512,540],"personal":[515,543,556,638,669,741,770,801,830,902],"consulting,":[518,559,641,672,744,773,804,833,905],"scientific":[522,563,645,676,748,777,808,837,909],"board,":[524,565,647,678,750,779,810,839,911],"speaking,":[525,566,648,679,751,780,811,840,912],"other":[527,568,650,681,753,782,813,842,914],"activities":[528,569,651,682,754,783,814,843,915],"Alder,":[531],"Theranica.":[538],"editorial":[547],"capacity":[548],"Springer":[550],"Scientific.":[551],"Lipton":[553,574,590,604,611,620],"Teva":[571],"Pharmaceuticals.":[572,664,786,796],"eNeura":[586],"Biohaven.":[588,618,756,765,816,825],"holds":[591,612,657,705,728,759,789,819,866,889,938,961],"stock":[592,594,613,615,658,660,706,708,729,731,760,762,790,792,820,822,867,869,890,892,939,941,962,964],"options":[595,616,661,709,732,763,793,823,870,893,942,965],"Biohaven":[597,653,663,684,700,711,734,785,795,845,861,872,895,917,933,944,967],"which":[598,602,714,718,875,879,947,951],"sponsored":[599,715,876,948],"involved":[606,722,883,955],"as":[607,723,884,956],"investigator.":[609,725,886,958],"Research":[627],"Foundation":[628,632],"National":[630],"Amgen.Dr.":[634],"Stock":[635,656],"Pharamceuticals.":[654],"Thiry":[666,688,704,720,727],"Pharmaceuticals,":[685,701,712,735,846,862,873,896],"Inc.":[686,702,713,736,847,863,874,897,919,935,946,969],"Conway":[738,758],"Jensen":[767,788],"Morris":[798,818],"Coric":[827,849,865,881,888],"Croop":[899,921,937,953,960],"Pharamceuticals,":[918,934,945,968]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-12-08T00:00:00"}